Corcept Therapeutics
CORT
#1871
Rank
โ‚น720.72 B
Marketcap
โ‚น6,831
Share price
-4.44%
Change (1 day)
223.18%
Change (1 year)

Revenue for Corcept Therapeutics (CORT)

Revenue in 2024 (TTM): โ‚น56.78 Billion

According to Corcept Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น57.57 Billion. an increase over the revenue in the year 2023 that were of โ‚น40.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Corcept Therapeutics from 2009 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น57.90 B44.21%
2023 โ‚น40.15 B20.76%
2022 โ‚น33.25 B22.08%
2021 โ‚น27.24 B5.25%
2020 โ‚น25.88 B18.41%
2019 โ‚น21.85 B24.41%
2018 โ‚น17.56 B72.82%
2017 โ‚น10.16 B83.94%
2016 โ‚น5.52 B65.37%
2015 โ‚น3.34 B98.58%
2014 โ‚น1.68 B163%
2013 โ‚น0.63 B253.38%
2012 โ‚น0.18 B
2011 N/A
2010 N/A-100%
2009 โ‚น1.39 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น7.576 T 13,057.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.119 T 7,055.13%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.411 T 7,562.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น3.841 T 6,572.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.427 T 9,325.52%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.473 T 9,405.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น28.34 B-50.77%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น24.35 B-57.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น243.42 B 322.78%๐Ÿ‡บ๐Ÿ‡ธ USA